메뉴 건너뛰기




Volumn 2, Issue 1, 2014, Pages

Efficacy and safety of single-dose liposomal amphotericin B for visceral leishmaniasis in a rural public hospital in Bangladesh: A feasibility study

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; CHLORPHENIRAMINE; MILTEFOSINE; PARACETAMOL; AMPHOTERICIN B; ANTIPROTOZOAL AGENT;

EID: 84890857397     PISSN: None     EISSN: 2214109X     Source Type: Journal    
DOI: 10.1016/S2214-109X(13)70118-9     Document Type: Article
Times cited : (63)

References (15)
  • 1
    • 84861665791 scopus 로고    scopus 로고
    • Leishmaniasis worldwide and global estimates of its incidence
    • Alvar J, Vélez ID, Bern C, et al. Leishmaniasis worldwide and global estimates of its incidence. PLoS One 2012, 7:e35671.
    • (2012) PLoS One , vol.7
    • Alvar, J.1    Vélez, I.D.2    Bern, C.3
  • 4
    • 79960244553 scopus 로고    scopus 로고
    • Phase IV trial of miltefosine in adults and children for treatment of visceral leishmaniasis (kala-azar) in Bangladesh
    • Rahman M, Ahmed BN, Faiz MA, et al. Phase IV trial of miltefosine in adults and children for treatment of visceral leishmaniasis (kala-azar) in Bangladesh. Am J Trop Med Hyg 2011, 85:66-69.
    • (2011) Am J Trop Med Hyg , vol.85 , pp. 66-69
    • Rahman, M.1    Ahmed, B.N.2    Faiz, M.A.3
  • 5
    • 84877283879 scopus 로고    scopus 로고
    • Increasing failure of miltefosine in the treatment of kala-azar in Nepal and the potential role of parasite drug resistance, reinfection, or noncompliance
    • Rijal S, Ostyn B, Uranw S, et al. Increasing failure of miltefosine in the treatment of kala-azar in Nepal and the potential role of parasite drug resistance, reinfection, or noncompliance. Clin Infect Dis 2013, 11:1530-1538.
    • (2013) Clin Infect Dis , vol.11 , pp. 1530-1538
    • Rijal, S.1    Ostyn, B.2    Uranw, S.3
  • 6
    • 79551683357 scopus 로고    scopus 로고
    • Comparison of short-course multidrug treatment with standard therapy for visceral leishmaniasis in India: an open-label, non-inferiority, randomized controlled trial
    • Sundar S, Sinha PK, Rai M, et al. Comparison of short-course multidrug treatment with standard therapy for visceral leishmaniasis in India: an open-label, non-inferiority, randomized controlled trial. Lancet 2011, 377:477-486.
    • (2011) Lancet , vol.377 , pp. 477-486
    • Sundar, S.1    Sinha, P.K.2    Rai, M.3
  • 8
    • 33748647413 scopus 로고    scopus 로고
    • Liposomal amphotericin B for the treatment of visceral leishmaniasis
    • Bern C, Adler-Moore J, Berenguer J, et al. Liposomal amphotericin B for the treatment of visceral leishmaniasis. Clin Infect Dis 2006, 43:917-924.
    • (2006) Clin Infect Dis , vol.43 , pp. 917-924
    • Bern, C.1    Adler-Moore, J.2    Berenguer, J.3
  • 9
    • 76649099805 scopus 로고    scopus 로고
    • Single-dose liposomal amphotericin B for visceral leishmaniasis in India
    • Sundar S, Chakravarty J, Agarwal D, Rai M, Murray H Single-dose liposomal amphotericin B for visceral leishmaniasis in India. N Engl J Med 2010, 362:504-512.
    • (2010) N Engl J Med , vol.362 , pp. 504-512
    • Sundar, S.1    Chakravarty, J.2    Agarwal, D.3    Rai, M.4    Murray, H.5
  • 10
    • 79957596962 scopus 로고    scopus 로고
    • WHO, (accessed Oct 22, 2013).
    • Control of the leishmaniases WHO, (accessed Oct 22, 2013). http://whqlibdoc.who.int/trs/WHO_TRS_949_eng.pdf.
    • Control of the leishmaniases
  • 11
    • 79953031840 scopus 로고    scopus 로고
    • Visceral leishmaniasis: elimination with existing interventions
    • Matlashewski G, Arana B, Kroeger A, et al. Visceral leishmaniasis: elimination with existing interventions. Lancet Infect Dis 2011, 11:322-325.
    • (2011) Lancet Infect Dis , vol.11 , pp. 322-325
    • Matlashewski, G.1    Arana, B.2    Kroeger, A.3
  • 12
    • 14744293250 scopus 로고    scopus 로고
    • Visceral leishmaniasis in pregnancy: a case series and a systematic review of the literature
    • Pagliano P, Carannante N, Rossi M, et al. Visceral leishmaniasis in pregnancy: a case series and a systematic review of the literature. J Antimicrob Chemother 2005, 55:229-233.
    • (2005) J Antimicrob Chemother , vol.55 , pp. 229-233
    • Pagliano, P.1    Carannante, N.2    Rossi, M.3
  • 13
    • 58749113633 scopus 로고    scopus 로고
    • Parasite susceptibility to amphotericin B in failures of treatment for visceral leishmaniasis in patients coinfected with HIV type 1 and Leishmania infantum
    • Lachaud L, Bourgeois N, Plourde M, Leprohon P, Bastien P, Ouellette M Parasite susceptibility to amphotericin B in failures of treatment for visceral leishmaniasis in patients coinfected with HIV type 1 and Leishmania infantum. Clin Infect Dis 2009, 48:e16-e22.
    • (2009) Clin Infect Dis , vol.48
    • Lachaud, L.1    Bourgeois, N.2    Plourde, M.3    Leprohon, P.4    Bastien, P.5    Ouellette, M.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.